Liu JC - Search Results

1

RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs.

Robinson TJ, Liu JC, Vizeacoumar F, Sun T, Maclean N, Egan SE, Schimmer AD, Datti A, Zacksenhaus E. Robinson TJ, et al. Among authors: liu jc. PLoS One. 2013 Nov 12;8(11):e78641. doi: 10.1371/journal.pone.0078641. eCollection 2013. PLoS One. 2013. PMID: 24265703 Free PMC article.

2

Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.

Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E. Liu JC, et al. Cancer Res. 2007 Sep 15;67(18):8671-81. doi: 10.1158/0008-5472.CAN-07-1486. Cancer Res. 2007. PMID: 17875707

3

Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.

Deng T, Liu JC, Pritchard KI, Eisen A, Zacksenhaus E. Deng T, et al. Among authors: liu jc. Clin Cancer Res. 2009 Jan 1;15(1):119-30. doi: 10.1158/1078-0432.CCR-08-1708. Clin Cancer Res. 2009. PMID: 19118039

4

Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. Jiang Z, et al. Among authors: liu jc. J Clin Invest. 2010 Sep;120(9):3296-309. doi: 10.1172/JCI41490. Epub 2010 Aug 2. J Clin Invest. 2010. PMID: 20679727 Free PMC article.

5

Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.

Adams JR, Xu K, Liu JC, Agamez NM, Loch AJ, Wong RG, Wang W, Wright KL, Lane TF, Zacksenhaus E, Egan SE. Adams JR, et al. Among authors: liu jc. Cancer Res. 2011 Apr 1;71(7):2706-17. doi: 10.1158/0008-5472.CAN-10-0738. Epub 2011 Feb 15. Cancer Res. 2011. PMID: 21324922

6

RB1 and p53 at the crossroad of EMT and triple-negative breast cancer.

Jiang Z, Jones R, Liu JC, Deng T, Robinson T, Chung PE, Wang S, Herschkowitz JI, Egan SE, Perou CM, Zacksenhaus E. Jiang Z, et al. Among authors: liu jc. Cell Cycle. 2011 May 15;10(10):1563-70. doi: 10.4161/cc.10.10.15703. Epub 2011 May 15. Cell Cycle. 2011. PMID: 21502814 Review.

7

Elevated PI3K signaling drives multiple breast cancer subtypes.

Adams JR, Schachter NF, Liu JC, Zacksenhaus E, Egan SE. Adams JR, et al. Among authors: liu jc. Oncotarget. 2011 Jun;2(6):435-47. doi: 10.18632/oncotarget.285. Oncotarget. 2011. PMID: 21646685 Free PMC article. Review.

8

Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.

Liu JC, Voisin V, Bader GD, Deng T, Pusztai L, Symmans WF, Esteva FJ, Egan SE, Zacksenhaus E. Liu JC, et al. Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5832-7. doi: 10.1073/pnas.1201105109. Epub 2012 Mar 28. Proc Natl Acad Sci U S A. 2012. PMID: 22460789 Free PMC article.

9

mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of β1 integrin function.

Li YJ, Liu G, Li Y, Vecchiarelli-Federico LM, Liu JC, Zacksenhaus E, Shan SW, Yang BB, Li Q, Dash R, Fisher PB, Archer MC, Ben-David Y. Li YJ, et al. Among authors: liu jc, liu g. Mol Cancer Res. 2013 Jun;11(6):593-603. doi: 10.1158/1541-7786.MCR-12-0496. Epub 2013 Mar 6. Mol Cancer Res. 2013. PMID: 23468528

10

A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions.

Liu JC, Egan SE, Zacksenhaus E. Liu JC, et al. Oncotarget. 2013 Aug;4(8):1317-28. doi: 10.18632/oncotarget.1170. Oncotarget. 2013. PMID: 23945331 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,524 results

Search Page

Filters